Please enter verification code
About SciencePG Frontiers
The column "SciencePG Frontiers" aims at presenting our authors’ latest publications of research achievements and speeding up the development of the science dissemination. SciencePG ensures that our authors get the recognition and rewards that they deserve and the opportunity to play a significant role in the global scientific community.
Publish your paper in SciencePG and write a promotional piece of news for your paper to gain more attention from the public.

Send your promotional news to:

Publication Services
Home / SciencePG Frontiers
A Anti Oxidative Medicine for Treatment COPD
Twice daily Qishenyiqi Dripping Pill(QDP), one type of new traditional Chinese medicine, 1000mg for the patients with COPD ,It can improve the lung founction of COPD.
By lingyun gao
Feb. 23, 2016

In a recent paper by author Dr.Lingyun Gao(LG), Described QDP, a Chinese medicine treatment for Chronic obstructive pulmonary disease (COPD).COPD affects millions of people worldwide and is known to be one of the leading causes of death.” Dr. Lingyun Gao said, COPD is a preventable and treatable disease characterized by progressive and persistent airflow obstruction. COPD exacerbations and the comorbid nature of the disease pose a significant and increasing economic and social burden.

Oxidative stress is an important trait in the pathogenesis of COPD. Consequently, targeting oxidative stress is likely to be beneficial as a treatment in COPD. Increased oxidative stress and inflammation play an important role in the pathogenesis of COPD. The drugs of anti-oxidation activity may be effective in treating COPD.

QDP is one type of traditional Chinese medicine. which is composed of Astragalus membranaceus (Huangqi), Salvia miltiorrhiza (Danshen), Panax notginseng (Sanqi), and Dalbergiao dorifera (Jiangxiang, DO). The major active ingredients are astragal side IV (ASIV, from Huanqi), 3, 4-dihydroxy-phenyl lactic acid (DLA, from Danshen), and notoginsenoside R1 (R1, from Sanqi). QDP has antioxidant therapy effects.

In this paper, Dr.LG found that twice daily QDP 1000mg for the patients with COPD. FEV1, FEV1/FVC and MMEF have improved in two groups after treatment. But more significantly was found in the experimental group, P value<0.05. Dr. LG said, “We found that QDP are associated with better clinical outcomes in those patients admitted to the general ward with a physician diagnosis of copd. QDP can significantly improve pulmonary function of patient with chronic obstructive pulmonary disease. AS the first study about QDP treatment COPD, future studies are needed to expand the sample size to confirm its influence in the prognosis of patients with COPD.” QDP provides a new method for the treatment of COPD. long-term use QDP may improve the prognosis of patients with COPD.

Traditional Chinese medicine has unique, and inexpensive in the treatment of COPD, it will help reduce the economic burden on patients and society. treatment of diseases use old drug also provides a method of treating ideas, and it will be worthy of clinical application.


Vice Prof. Dr. med. Lingyun Gao

Department of Respiratory Medicine, Sichuan Academy of Medical &Sichuan Provincial People's Hospital , Chengdu, Sichuan province, China.

Paper link:

Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186